DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery

References

• Al-Jamal KT, Gherardini L, Bardi G, et al. (2011). Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc Natl Acad Sci USA 108:10952–7
   PubMed Web of Science ®Google Scholar
• Al-Jamal KT, Toma FM, Yilmazer A, et al. (2010). Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube:siRNA complexes. FASEB J 24:4354–65
   PubMed Web of Science ®Google Scholar
• Bates K, Kostarelos K. (2013). Carbon nanotubes as vectors for gene therapy: past achievements, present challenges and future goals. Adv Drug Deliv Rev 65:2023–33
   PubMed Web of Science ®Google Scholar
• Battigelli A, Wang JT, Russier J, et al. (2013). Ammonium and guanidinium dendron-carbon nanotubes by amidation and click chemistry and their use for siRNA delivery. Small 9:3610–9
   PubMed Web of Science ®Google Scholar
• Chen H, Ma X, Li Z, et al. (2012). Functionalization of single-walled carbon nanotubes enables efficient intracellular delivery of siRNA targeting MDM2 to inhibit breast cancer cells growth. Biomed Pharmacother 66:334–8
   PubMed Web of Science ®Google Scholar
• Firme Iii CP, Bandaru PR. (2010). Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine (Lond) 6:245–56
   Web of Science ®Google Scholar
• Foldvari M, Bagonluri M. (2008). Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomedicine 4:183–200
   Google Scholar
• Gandellini P, Folini M, Bandiera R, et al. (2007). Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment. Biochem Pharmacol 73:1703–14
   PubMed Web of Science ®Google Scholar
• Gao J, Liu W, Xia Y, et al. (2011). The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes. Biomaterials 32:3459–70
   PubMed Web of Science ®Google Scholar
• Guo J, Bourre L, Soden DM, et al. (2011). Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? Biotechnol Adv 29:402–17
   PubMed Web of Science ®Google Scholar
• Krajcik R, Jung A, Hirsch A, et al. (2008). Functionalization of carbon nanotubes enables non-covalent binding and intracellular delivery of small interfering RNA for efficient knock-down of genes. Biochem Biophys Res Commun 369:595–602
   PubMed Web of Science ®Google Scholar
• Kurreck J. (2009). RNA interference: from basic research to therapeutic applications. Angew Chem Int Ed Engl 48:1378–98
   PubMed Web of Science ®Google Scholar
• Lanone S, Andujar P, Kermanizadeh A, et al. (2013). Determinants of carbon nanotube toxicity. Adv Drug Deliv Rev 65:2063–9
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim SH, Park TG. (2007). Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Biochem Biophys Res Commun 357:511–16
   PubMed Web of Science ®Google Scholar
• Li H, Zhang N, Hao Y, et al. (2013). Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro. Drug delivery doi:0.3109/10717544.2013.848246
   Web of Science ®Google Scholar
• Liang Y, Liu Z, Shuai X, et al. (2012). Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration. Biochem Biophys Res Commun 421:690–5
   PubMed Web of Science ®Google Scholar
• Liu Z, Tabakman SM, Chen Z, et al. (2009). Preparation of carbon nanotube bioconjugates for biomedical applications. Nature Protoc 4:1372–82
   PubMed Web of Science ®Google Scholar
• Liu Z, Winters M, Holodniy M, et al. (2007). siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew Chem Int Ed 46:2023–7
   PubMed Web of Science ®Google Scholar
• McCarroll J, Baigude H, Yang CS, et al. (2010). Nanotubes functionalized with lipids and natural amino acid dendrimers: a new strategy to create nanomaterials for delivering systemic RNAi. Bioconjug Chem 21:56–63
   PubMed Web of Science ®Google Scholar
• Podesta JE, Al-Jamal KT, Herrero MA, et al. (2009). Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model. Small 5:1176–85
   PubMed Web of Science ®Google Scholar
• Pulskamp K, Diabaté S, Krug HF. (2007). Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 168:58–74
   PubMed Web of Science ®Google Scholar
• Siu KS, Chen D, Zheng X, et al. (2014). Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma. Biomaterials 35:3435–42
   PubMed Web of Science ®Google Scholar
• Varkouhi AK, Foillard S, Lammers T, et al. (2011). SiRNA delivery with functionalized carbon nanotubes. Int J Pharm 416:419–25
   PubMed Web of Science ®Google Scholar
• Vichai V, Kirtikara K. (2006). Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protocols 1:1112–16
   PubMed Web of Science ®Google Scholar
• Wang L, Shi J, Zhang H, et al. (2013). Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes. Biomaterials 34:262–74
   PubMed Web of Science ®Google Scholar
• Wang X, Ren J, Qu X. (2008). Targeted RNA interference of cyclin A2 mediated by functionalized single-walled carbon nanotubes induces proliferation arrest and apoptosis in chronic myelogenous leukemia K562 cells. Chem Med Chem 3:940–5
   Web of Science ®Google Scholar
• Wick P, Manser P, Limbach LK, et al. (2007). The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol Lett 168:121–31
   PubMed Web of Science ®Google Scholar
• Xia W, Wang P, Lin C, et al. (2012). Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo. J Control Release 157:427–36
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang X, Zhang Y, et al. (2006). Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth. Clin Cancer Res 12:4933–9
   PubMed Web of Science ®Google Scholar